Activist investor renews its criticism of Novavax Shah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a "destruction in shareholder value."

#Hedgefund #ShahCapital has fired another broadside at vaccine developer #Novavax, saying it intends to vote against the re-election of the #board and executive pay packages at its forthcoming annual meeting.

Investor seeks sale of Novavax after poor COVID jab sales Investor Shah Capital has called on Novavax's board to put the company up for sale, citing a "litany of missteps" at the vaccine developer.

Activist investor #ShahCapital has called on the #board of directors at #Novavax to put the company up for sale, citing a "litany of missteps" at the company.

pharmaphorum.com/news/investo...